TrialJournal of the American Heart Association2020

Acute and Chronic Effects of SGLT2 Inhibitor Empagliflozin on Renal Oxygenation and Blood Pressure Control in Nondiabetic Normotensive Subjects: A Randomized, Placebo-Controlled Trial.

Anne Zanchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.